These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3105245

  • 1. Changes in serotype caused by cell to cell contact between different Pseudomonas aeruginosa strains from cystic fibrosis patients.
    Ojeniyi B, Rosdahl VT, Høiby N.
    Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):23-7. PubMed ID: 3105245
    [Abstract] [Full Text] [Related]

  • 2. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa.
    Ojeniyi B.
    APMIS; 1988 Apr; 96(4):294-8. PubMed ID: 3130885
    [Abstract] [Full Text] [Related]

  • 3. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B.
    APMIS Suppl; 1994 Apr; 46():1-44. PubMed ID: 7811529
    [Abstract] [Full Text] [Related]

  • 4. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B, Wolz C, Döring G, Lam JS, Rosdahl VT, Høiby N.
    APMIS; 1990 May; 98(5):423-31. PubMed ID: 2113398
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa in isolates from cystic fibrosis patients.
    Ojeniyi B, Høiby N, Rosdahl VT.
    APMIS; 1991 Feb; 99(2):187-95. PubMed ID: 1900422
    [Abstract] [Full Text] [Related]

  • 6. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B, Høiby N, Rosdahl VT.
    APMIS; 1991 Jun; 99(6):492-8. PubMed ID: 1905144
    [Abstract] [Full Text] [Related]

  • 7. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. The International Pseudomonas aeruginosa Typing Study Group.
    J Infect Dis; 1994 Jan; 169(1):134-42. PubMed ID: 7903973
    [Abstract] [Full Text] [Related]

  • 8. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    Miller RV, Rubero VJ.
    J Clin Microbiol; 1984 May; 19(5):717-9. PubMed ID: 6429192
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies.
    Ojeniyi B, Lam JS, Høiby N, Rosdahl VT.
    APMIS; 1989 Jul; 97(7):631-6. PubMed ID: 2502162
    [Abstract] [Full Text] [Related]

  • 10. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B, Petersen US, Høiby N.
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.
    Leone I, Chirillo MG, Raso T, Zucca M, Savoia D.
    Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1093-9. PubMed ID: 18488256
    [Abstract] [Full Text] [Related]

  • 12. Epidemiological estimation of Pseudomonas aeruginosa strains isolated from different environments.
    Cybulski Z, Michalska W, Pietkiewicz K.
    Acta Microbiol Pol; 1993 Nov; 42(3-4):259-65. PubMed ID: 7516617
    [Abstract] [Full Text] [Related]

  • 13. Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
    Fomsgaard A, Conrad RS, Galanos C, Shand GH, Høiby N.
    J Clin Microbiol; 1988 May; 26(5):821-6. PubMed ID: 3133386
    [Abstract] [Full Text] [Related]

  • 14. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
    Hafiane A, Ravaoarinoro M.
    Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
    [Abstract] [Full Text] [Related]

  • 15. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
    Kelly NM, Fitzgerald MX, Tempany E, O'Boyle C, Falkiner FR, Keane CT.
    Lancet; 1982 Sep 25; 2(8300):688-90. PubMed ID: 6126629
    [Abstract] [Full Text] [Related]

  • 16. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Dunne WM, Chusid MJ.
    Diagn Microbiol Infect Dis; 1987 Feb 25; 6(2):165-70. PubMed ID: 3102157
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.
    Bingen E, Denamur E, Picard B, Goullet P, Lambert-Zechovsky N, Foucaud P, Navarro J, Elion J.
    Eur J Clin Microbiol Infect Dis; 1992 May 25; 11(5):432-7. PubMed ID: 1358612
    [Abstract] [Full Text] [Related]

  • 18. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.
    McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ.
    Lancet; 2001 Aug 18; 358(9281):558-60. PubMed ID: 11520530
    [Abstract] [Full Text] [Related]

  • 19. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis.
    Penketh A, Pitt T, Roberts D, Hodson ME, Batten JC.
    Am Rev Respir Dis; 1983 May 18; 127(5):605-8. PubMed ID: 6405665
    [Abstract] [Full Text] [Related]

  • 20. Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.
    Millesimo M, de Intinis G, Chirillo MG, Musso T, Savoia D.
    Eur J Epidemiol; 1996 Apr 18; 12(2):123-9. PubMed ID: 8817189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.